Simulated annealing with restrained molecular dynamics using CONGEN: Energy refinement of the NMR solution structures of epidermal and type-α transforming growth factors

Protein Science

Volumn 5, Issue 4, 1996, Pages 578-592

  Tejero, Roberto ^a,c   Bassolino Klimas, Donna ^b   Bruccoleri, Robert E ^b   Montelione, Gaetano T ^a  

^a RUTGERS UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

conformational energy; conformational pinning; NMR structure refinement

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; COMPUTER PROGRAM; COMPUTER SIMULATION; ENERGY RESOURCE; HUMAN; HUMAN CELL; IMMUNOASSAY; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY;

EID: 0029920419     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050403     Document Type: Article

References (46)

1. Baron N, Norman DG, Harvey TS, Handford PA, Mayhew M, Tse AGD, Brownlee GG, Campbell ID. 1992. The three-dimensional structure of the first EGF-like module of human factor IX: Comparison with EGF and TGF-alpha. Protein Sci 1:81-90.
2. Bassolino-Klimas D, Tejero R, Krystel SR, Metzler WJ, Montelione GT, Bruccoleri RE. 1996. Simulated annealing with restrained molecular dynamics using a flexible restraint potential Theory and evaluation with simulated NMR constraints. Protein Sci 5:593-603.
3. Braun W, Go N. 1985. Calculation of protein conformations by proton-proton distance constraints. A new efficient algorithm. J Mol Biol 186:611-626.
4. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swammathan S, Karplus M. 1983. CHARMM: A program for macromolecular energy minimization and dynamics calculations J Comp Chem 4:187-217.
5. Bruccoleri RE, Karplus M. 1987. Prediction of the folding of short polypeptide segments by uniform conformational sampling. Biopolymers 26:137-168.
6. Burgess AW. 1989. Epidermal growth factor and transforming growth factor alpha. Br Med Bull 45:401-424
7. Campbell ID, Bork P. 1993. Epidermal growth factor-like modules. Curr Opin Struct Biol 3:385-392
8. Carpenter G, Stoscheck CM, Preston YA, DeLarco JE. 1983. Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. Proc Natl Acad Sci USA 80:5627-5630.
9. Carson M. 1991. RIBBONS 2.0. J Appl Cryst 24:958-961.
10. α heteronuclear NOE data in monitoring a protein NMR structure refinement. J Biomol NMR 5:161-172.
11. Cohen S. 1962. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 237:1555-1562.
12. Constantine KL, Friedrichs MS, Mueller L, Bruccoleri RE. 1995a. J-coupling restraint potentials for non-stereospecifically assigned methylene protons and ensemble average calculations. J Magn Reson Ser B 108:176-184.
13. Constantine KL, Mueller L, Anderson NH, Tong H, Wandler CF, Friedrichs MS, Bruccoleri RE. 1995b. Structural and dynamical properties of a β-hairpin-forming linear peptide. 1. Modeling using ensemble-averaged constraints. J Am Chem Soc 177:10841-10854.
14. Cooke RM, Wilkinson AJ, Baron M, Pastore A, Tappin MJ, Campbell ID, Gregory H, Sheard B. 1987. The solution structure of human epidermal growth factor. Nature 327:339-341.
15. Fadel AR, Jin DQ, Montelione GT, Levy RM. 1995. Crankshaft motions of the polypeptide backbone in molecular dynamics simulations of human type-α transforming growth factor. J Biomol NMR 6:221-226.
16. Graves BJ, Crowther RL, Chandran C, Rumberger JM, Li S, Huang KS, Presky DH, Familletti PC, Wolitzky BA, Burns DK. 1994. Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature 367:532-538.
17. Groenen LC, Nice EC, Burgess AW. 1994. Structure-function relationships for the EGF/TGFα family of mitogens. Growth Factors 11:235-237.
18. Guerin M, Gabillot M, Mathieu MC, Travagli JP, Spielmenn M, Andrieu N, Riou G. 1989. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: Prognostic significance. Int J Cancer 43:201-208
19. Hansen AP, Petros AM, Meadows RP, Nettesheim DG, Mazar AP, Olejmczak ET, Xu RX, Pederson TM, Henkin J, Fesik SW. 1994. Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry 33:4847-4864.
20. Harvey TS, Wilkinson AJ, Tappin MJ, Cooke RM, Campbell ID. 1991. The solution structure of human transforming growth factor alpha. Eur J Biochem 198:555-562.
21. Hendrickson WA, Teeter MM. 1981. Structure of the hydrophobic protein crambin determined directly from the anomalous scattering of sulfur. Nature 290:107-113.
22. Hommel U, Harvey TS, Driscoll PC, Campbell ID. 1992. Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha. J Mol Biol 227:271-282.
23. 1H NMR assignments, secondary structure, and location of the calcium binding site in the first epidermal growth factor like domain of blood coagulation factor IX. Biochemistry 30:7402-7409.
24. Hyberts SG, Goldberg MS, Havel TF, Wagner G. 1992. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci 1:736-751.
25. Ikura T, Gō N. 1993 Normal mode analysis of mouse epidermal growth factor: Characterization of the harmonic motion. Proteins Struct Funct Genet 16:423-436.
26. 1H NMR data Biochemistry 29:7805-7813.
27. Kohda D, Inagaki F. 1992a. Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. Biochemistry 31:11928-11939.
28. Kohda D, Inagaki F. 1992b. Structure of epidermal growth factor bound to perdeuterated dodecylphosphocholine micelles determined by two-dimensional NMR and simulated annealing calculations. Biochemistry 31:677-685.
29. Li YC, Montelione GT. 1995. Human type-α transforming growth factor undergoes slow conformational exchange between multiple backbone conformations as characterized by nitrogen-15 relaxation measurements. Biochemistry 34:2408-2423.
30. Montelione GT, Arnold E, Meinwald YC, Stimson ER, Denton JB, Huang SG, Clardy J, Scheraga HA. 1984. Chain-folding initiation structures in ribonuclease A: Conformational analysis of trans Ac-Asn-Pro-Tyr-NHMe and Ac-Tyr-Pro-Asn-NHMe in water and in the solid state J Am Chem Soc 106:7946-7958.
31. Montelione GT, Wüthrich K, Burgess AW, Nice EC, Wagner G, Scheraga HA. 1992. Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization. Biochemistry 31:236-249.
32. 1H-NMR. Proc Natl Acad Sci USA 83:8594-8598.
33. Montelione GT, Wüthrich K, Nice EC, Burgess AW, Scheraga HA. 1987. Solution structure of murine epidermal growth factor: Determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry. Proc Natl Acad Sci USA 84:5226-5230.
34. 1H-NMR resonance assignments and identification of slowly exchanging amide protons in the solution structure of murine epidermal growth factor. Biochemistry 27:2235-2243.
35. Moy FJ, Li YC, Rauenbuehler P, Winkler ME, Scheraga HA, Montelione GT. 1993. Solution structure refinement of human type-α transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints. Biochemistry 32:7334-7353.
36. Nemethy G, Gibson KD, Palmer KA, Yoon CN, Paterlini G, Zagari A, Rumsey S, Scheraga HA. 1992. Energy parameters in polypeptides. 10: improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with applications to proline-containing peptides. J Phys Chem 96:6472-6484.
37. Némethy G, Pottle MS, Scheraga HA. 1983. Energy parameters in peptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occurring amino acids. J Phys Chem 87:1883-1887.
38. Padmanabhan K, Padmanabhan KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W. 1993. Structure of human des(1-45) factor Xa at 2.2 Å resolution. J Mol Biol 232:947-966.
39. Selander-Sunnerhagen M, Ullner M, Persson M, Teleman O, Stenflo J, Drakenberg T. 1992. How an epidermal growth factor (EGF)-like domain binds calcium: High resolution NMR structure of the calcium form of the amino-terminal EGF-like domain in coagulation factor X. J Biol Chem 257:19642-19649.
40. Simpson RJ, Smith JA, Moritz RL, O'Hare MJ, Rudland PS, Morrison JR, Lloyd CJ, Grego B, Burgess AW, Nice EC. 1985. Rat epidermal growth factor: Complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity. Eur J Biochem 153: 629-637.
41. Smith BO, Downing AK, Dudgeon TJ, Cunningham M, Driscoll PC, Campbell ID. 1994. Secondary structure of fibronectin type 1 and epidermal growth factor modules from tissue-type plasminogen activator by nuclear magnetic resonance. Biochemistry 33:2422-2429.
42. 1H-NMR study of human transforming growth factor alpha. Structure and pH-dependent conformational interconversion. Eur J Biochem 179: 629-637
43. Ullner M, Selander M, Persson E, Stenflo J, Drakenberg T, Teleman O. 1992. Three-dimensional structure of the apo form of the N-terminal EGF-like module of blood coagulation factor X as determined by NMR spectroscopy and simulated folding. Biochemistry 31:5974-5983.
44. Verlet L. 1967. Computer experiments on classical fluids. I. Thermodynamic properties of Lennard-Jones molecules Phys Rev 159:98-103.
45. Weis WI. 1994. Lectins on a roll: The structure of E-selectin. Structure 2: 147-150.
46. Wüthrich K. 1986. NMR of proteins and nucleic acids. New York: John Wiley & Sons.